-
Additional file 4: Table S4. of The contribution of Alu exons to the human pr...
List of RT-PCR primers. (XLSX 10 kb) -
Additional file 18 of Some data quality issues at ClinicalTrials.gov
Processing of PI names to identify ambiguities—step 2. (XLSX 1406 kb) -
Additional file 3: of Alternative DNA secondary structure formation affects R...
A list of 5959 pausing sites located outside of RefSeq gene bodies. (DAT 234 kb) -
Additional file 3: of Exome analysis of carotid body tumor
List of evaluated potentially driver mutations and their detailed description. (XLSX 22Â kb) -
Additional file 14 of Some data quality issues at ClinicalTrials.gov
The 10,572 rejected rows in Additional file 13: Table S11 came from 8907 unique NCT IDs. (ODS 203 kb) -
Additional file 2: of 3CPET: finding co-factor complexes from ChIA-PET data u...
Excel file listing the inferred ER-alpha and RNAP-II related networks. (XLSX 35 kb) -
dedup_wf_001--c17aeabb68855f0e9598bdba1b82e8da
Figure S1. A, IF analysis of CD49f and ERα co-expression in prostate tissues, enriched stem cell spheres of LNCaP-abl (PCSCs), LNCaP-abl or PC3 cells. Scale bar, 50 μm. B, Mean... -
Additional file 4: of Umbilical cord as a long-term source of activatable mes...
Table S3. Contains a list of upstream regulators from Ingenuity Pathway Analysis (IPA) of the significantly deregulated genes from Additional file 3: Table S2. (XLSX 23 kb) -
dedup_wf_001--02bded384f8468d9a38014fc077f2929
List of all significant pathways associated with the molecular initiating event (MIE), each key event (KE), and each associative event (AE) including the benchmark dose (BMD)... -
Additional file 1: of Clinical long-time course, novel mutations and genotype...
List of all mutations in POMT1. This file lists all causative mutations identified to date in the POMT1 gene. (XLSX 27 kb) -
Additional file 4: of ADAR1 promotes the epithelial-to-mesenchymal transition...
Figure S4. Real-time PCR assay was used to detect miR-21–3p, miR-18a-3p, miR-210-3p, miR-155-5p, miR-181a-5p and miR-19a-3p expression. The data were summarized from at least... -
Guest Inclusion and Structural Dynamics in 2-D Hydrogen-Bonded Metal−Organic ...
Guest Inclusion and Structural Dynamics in 2-D Hydrogen-Bonded Metal−Organic Frameworks -
Prevention of ovarian hyperstimulation syndrome in a rat model: comparison of...
The aim of the study is to investigate the effects of the interleukin-6 (IL-6) blocker tocilizumab in a hyperstimulated rat model and compare it with ranibizumab, a... -
The contribution of trees and palms to a balanced diet in three rural village...
Improving the quality of people’s diets represents a major challenge for developing countries, particularly in Sahelian African countries. Foods from trees, shrubs, and palms... -
Additional file 9 of Some data quality issues at ClinicalTrials.gov
Records with a primary completion date and registered with an authority in the USA. The data (5101 records from Additional file 7: Table S5) were sorted into a... -
Additional file 15 of Some data quality issues at ClinicalTrials.gov
PIs in the history records of a sample of Additional file 10: Table S8 rejects and Additional file 13: Table S11 rejects. (ODS 219 kb) -
Additional file 11 of Some data quality issues at ClinicalTrials.gov
Records that list matching numbers of names and roles of the investigators. The data (31,392 records from Additional file 10: Table S8) were sorted into the “MatchedPipes”... -
Additional file 12 of Some data quality issues at ClinicalTrials.gov
Data in the form of individual investigators and their matching roles. The data (31,375 records from Additional file 11: Table S9) were sorted into a “LineByLine” sheet, where... -
MOESM3 of Increased β-Lactams dosing regimens improve clinical outcome in cri...
Additional file 3. Distribution of propensity score between treatment and control groups. -
Additional file 5 of Some data quality issues at ClinicalTrials.gov
Records of drugs or biologicals. Records with “drug:”, “biological: ”, or both of these words in the “intervention” field are listed in a “Drugs+Bio” sheet, with the remaining...
